Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Investigation Into the Effects of Diidolylmethane (BioResponse DIM®) Supplementation in Women With Low-Grade Cervical Cytological Abnormalities [CRISP-1]

NCT00462813 is registered in ClinicalTrials.gov with Barts and the London School of Medicine and Dentistry as lead sponsor.

NCT NCT00462813
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00462813 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Investigation Into the Effects of Diidolylmethane (BioResponse DIM®) Supplementation in Women With Low-Grade Cervical Cytological Abnormalities [CRISP-1]
Lead sponsor
Barts and the London School of Medicine and Dentistry
Phase
Phase 3
Overall status
Completed
Start date
October 31, 2004
Completion date
January 31, 2010
Enrollment
3,000 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cervical cancer, precancerous condition